TY - JOUR
AB - Drugs & Therapy Perspectives (2022) 38:221 https://doi.org/10.1007/s40267-022-00911-z DRUG REAC TIONS AND INTER AC TIONS Accepted: 4 April 2022 © Springer Nature Switzerland AG 2022 Table 1 contains an overview of r fi st published case reports of scientic fi meetings, media releases, regulatory agency web - adverse drug reactions and interactions identified in the inter - sites, and bulletins from the National Centers that participate national literature in recent weeks by Reactions Weekly, the in the WHO International Drug Monitoring Programme. Adis drug safety newsletter. Reactions Weekly provides sum- maries of adverse drug reaction news sourced from journals, Table 1 First reports of adverse drug reactions Drug: adverse reaction (all serious) Reference Adalimumab + azathioprine: Kikuchi-Fujimoto disease Shaikh DH, et al. First reported case of Kikuchi-Fujimoto disease in a Crohn's disease patient [abstract no. S2397]. Am J Gastr oente rol. 2021; 116(Suppl.): S1017 Azelnidipine: complete atrioventricular block Ide N, et al. A case of complete atrioventricular block with extremely high blood concentration of azelnidipine. J Pharm Healt h Care Sci. 2021; 7(1): 48 Bevacizumab: oesophageal pleural fistula Wang T, et al. Bevacizumab-induced esophageal pleural fistula during maintenance therapy without radiation in lung cancer. BMC Pulm Med. 2021; 21(1): 384 Blinatumomab: pneumatosis intestinalis Kim SE, et al. Blinatumomab-related pneumatosis intestinalis 
TI - First reports of adverse drug reactions
JO - Drugs & Therapy Perspectives
DO - 10.1007/s40267-022-00911-z
DA - 2022-05-16
UR - https://www.deepdyve.com/lp/pubmed-central/first-reports-of-adverse-drug-reactions-M0oRg0wC0x
SP - 221
EP - 221
VL - 38
IS - 5
DP - DeepDyve
ER -